Neuroinflammatory disease

The neuroinflammatory diseases care programme participates in clinical trials with new drugs. Drugs of which preliminairy data suggests that they might influency the natural course of MS beneficially.

For more information on currently ongoing trials, you can contact Prof. Dr. B. Dubois (+32 16 344280) or Mrs. K. Clijsters (+32 16 347294).